Beta Bionics Inc. Share Price Today: Live Updates & Key Insights

Beta Bionics Inc. share price today is $10.73, up -0.93%. The stock opened at $10.8 against the previous close of $10.8, with an intraday high of $10.91 and low of $10.54.

Beta Bionics Inc. Share Price Chart

Beta Bionics Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Beta Bionics Inc. Share Price Performance

$10.73 -0.0093(-0.93%) BBNX at 23 Mar 2026 12:09 PM Medical Devices
Lowest Today 10.54
Highest Today 10.91
Today’s Open 10.8
Prev. Close 10.8
52 Week High 32.71
52 Week Low 8.89
Day’s Range: Low 10.54 High 10.91
52-Week Range: Low 8.89 High 32.71
1 day return -
1 Week return -1.56
1 month return -22.2
3 month return -66.15
6 month return -53.28
1 year return -27.86
3 year return -
5 year return -
10 year return -

Beta Bionics Inc. Institutional Holdings

Beta Bionics Inc. Market Status

Strong Buy: 4

Buy: 1

Hold: 2

Sell: 0

Strong Sell: 0

Beta Bionics Inc. Fundamentals

Market Cap 474.89 M

PB Ratio 1.6527

PE Ratio 0.0

Enterprise Value 263.51 M

Total Assets 328.74 M

Volume 1714171

Beta Bionics Inc. Company Financials

Annual Revenue FY25:100251000 100.3M

Annual Profit FY25:55537000 55.5M

Annual Net worth FY25:-73200000 -73.2M

Quarterly Revenue Q4/2025:32121000 32.1M, Q3/2025:27253000 27.3M, Q2/2025:23238000 23.2M, Q1/2025:17639000 17.6M

Quarterly Profit Q4/2025:18944000 18.9M, Q3/2025:15119000 15.1M, Q2/2025:12503000 12.5M, Q1/2025:8971000 9.0M

Quarterly Net worth Q4/2025:-13466000 -13.5M, Q3/2025:-14209000 -14.2M, Q2/2025:-16869000 -16.9M, Q1/2025:-28656000 -28.7M

About Beta Bionics Inc. & investment objective

Company Information Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.

Organisation Medical Devices

Employees 420

Industry Medical Devices

CEO Mr. Sean T. Saint PE

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Beta Bionics Inc. FAQs

What is the share price of Beta Bionics Inc. today?

The current share price of Beta Bionics Inc. is $10.73.

Can I buy Beta Bionics Inc. shares in India?

Yes, Indian investors can buy Beta Bionics Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Beta Bionics Inc. shares in India?

You can easily invest in Beta Bionics Inc. shares from India by:

Can I buy fractional shares of Beta Bionics Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Beta Bionics Inc.?

Beta Bionics Inc. has a market cap of $474.89 M.

In which sector does Beta Bionics Inc. belong?

Beta Bionics Inc. operates in the Medical Devices sector.

What documents are required to invest in Beta Bionics Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Beta Bionics Inc.?

The PE ratio of Beta Bionics Inc. is N/A and the PB ratio is 1.65.